A meta-analysis consisting of 29 studies and 4726 HCC patients highlighted that AFP level was a potential noninvasive prognosis marker for HCC patients, and AFP Slope > 7.5 ng/mL per month was associated with HCC recurrence post-liver transplantation [32]. This evidence concerns the gene AFP and hepatocellular carcinoma.